October

October 7, 2014

Natural product-based therapy for Human cancer: Kefir, a traditional fermented milk product, inhibits tumor cell proliferation via down regulation of Superoxide dismutase 1 (SOD1), 7/October/2014, 15.09

The 1989 Nobel prize winner in Physiology/Medicine Prof. Varmus Harold E, Somwar R and others from High Throughput Screening Core Facility, and Organic Synthesis Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; and the US National […]
October 7, 2014

Anti-cancer stem cell therapeutics: Tumor suppressor ING1b inhibits mammary cancer stem cell proliferation via down regulation of Wnt receptor FZD7, 7/October/2014, 14.53

A study from the Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA shows that “ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer […]
October 7, 2014

Molecular therapy for Human Leukemias: NR2F2 suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 7/October/2014, 14.40

The 1975 Nobel laureate in Physiology/Medicine Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the July 8, 2014 Blood that: “Dual mechanisms by which MiR-125b represses IRF4 to induce myeloid […]
October 7, 2014

Differentiation therapy for Human Leukaemia: Resistin functions as an anti-cancer barrier by promoting differentiation of leukaemic cells via up regulation of Histone methyl-transferase MLL4, 7/October/2014, 12.30 pm

A recent study from the Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA shows that “DNA-damage-induced differentiation of leukaemic cells as an […]